1,252
Views
35
CrossRef citations to date
0
Altmetric
CLINICAL STUDY

Secondary Hyperparathyroidism in Chronic Hemodialysis Patients: Prevalence and Race

, M.D., , M.D., , M.D., , M.D. & , M.D.
Pages 595-602 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Cheng-Hao Weng, Ching-Chih Hu, Tzung-Hai Yen & Wen-Hung Huang. (2015) Association between ambient carbon monoxide and secondary hyperparathyroidism in nondiabetic patients undergoing peritoneal dialysis. Therapeutics and Clinical Risk Management 11, pages 1401-1408.
Read now
Farhanah Yousaf & Chaim Charytan. (2014) Review of cinacalcet hydrochloride in the management of secondary hyperparathyroidism. Renal Failure 36:1, pages 131-138.
Read now
Anne C. Beaubrun, M. Alan Brookhart, Betsy Sleath, Lily Wang & Abhijit V. Kshirsagar. (2013) Trends and Variations in Intravenous Vitamin D Use among Hemodialysis Patients in the United States. Renal Failure 35:1, pages 1-8.
Read now
Rob Boer, Anjana M. Lalla & Vasily Belozeroff. (2012) Cost-effectiveness of cinacalcet in secondary hyperparathyroidism in the United States. Journal of Medical Economics 15:3, pages 509-520.
Read now

Articles from other publishers (31)

Aarti Mathur, JiYoon B Ahn, Whitney Sutton, Nadia M Chu, Alden L Gross, Dorry L Segev & Mara McAdams-DeMarco. (2022) Secondary hyperparathyroidism (CKD-MBD) treatment and the risk of dementia. Nephrology Dialysis Transplantation 37:11, pages 2111-2118.
Crossref
Aarti Mathur, JiYoon B. Ahn, Whitney Sutton, Martha A. Zeiger, Dorry L. Segev & Mara McAdams-DeMarco. (2022) Increasing rates of parathyroidectomy to treat secondary hyperparathyroidism in dialysis patients with Medicare coverage. Surgery 172:1, pages 118-126.
Crossref
Ayse Zengin, Cat Shore-Lorenti, Marc Sim, Louise Maple-Brown, Sharon Lee Brennan-Olsen, Joshua R Lewis, Jennifer Ockwell, Troy Walker, David Scott & Peter Ebeling. (2022) Why Aboriginal and Torres Strait Islander Australians fall and fracture: the codesigned Study of Indigenous Muscle and Bone Ageing (SIMBA) protocol. BMJ Open 12:4, pages e056589.
Crossref
Xue Xue, Chun-li Lu, Hong Cheng, Xin-yan Jin, Xue-han Liu, Min Yang, Wen-cheng Xu, Qiang Liu, Jun Yuan, Jian-ping Liu & Xiao-qin Wang. (2021) Factor analysis of Traditional Chinese Medicine syndromes and clinical characteristics of patients with secondary hyperparathyroidism maintained by hemodialysis: A cross-sectional study. European Journal of Integrative Medicine 47, pages 101373.
Crossref
Marquita B. Winder, Darius L. Mason, Janani Rangaswami, Arif Asif, Tushar J. Vachharajani & Roy O. Mathew. (2021) Racial differences in the relationship between high-normal 25-hydroxy vitamin d and parathyroid hormone levels in early stage chronic kidney disease. Brazilian Journal of Nephrology 43:1, pages 34-40.
Crossref
Lin Liu, Dongsheng Hong, Kuifen Ma, Bin Wu & Xiaoyang Lu. (2020) Cost-effectiveness analysis of cinacalcet for haemodialysis patients with moderate-to-severe secondary hyperparathyroidism in China: evaluation based on the EVOLVE trial. BMJ Open 10:8, pages e034123.
Crossref
Brittany Greene, S. Joseph Kim, Ellen P. McCarthy & Jesse D. Pasternak. (2019) Effects of Social Disparities on Management and Surgical Outcomes for Patients with Secondary Hyperparathyroidism. World Journal of Surgery 44:2, pages 537-543.
Crossref
Megan L. Salter, Xinran Liu, Sunjae Bae, Nadia M. Chu, Alexandra Miller Dunham, Casey Humbyrd, Dorry L. Segev & Mara A. McAdams‐DeMarco. (2019) Fractures and Subsequent Graft Loss and Mortality among Older Kidney Transplant Recipients. Journal of the American Geriatrics Society 67:8, pages 1680-1688.
Crossref
Ayse Zengin, Louise J. Maple-Brown, Sharon Brennan-Olsen, Jacqueline R. Center, Sandra Eades & Peter R. Ebeling. (2018) Musculoskeletal health of Indigenous Australians. Archives of Osteoporosis 13:1.
Crossref
Erwin A. Gorter, Anthony J. C. G. D. Kluck, Pieta Krijnen & Inger B. Schipper. (2017) Pathological fractures in a patient with severe osteomalacia and hyperparathyroidism: a multidisciplinary challenge. Archives of Osteoporosis 12:1.
Crossref
Hee Jung Jeon, Yong Chul Kim, Seokwoo Park, Clara Tammy Kim, Jongwon Ha, Duck Jong Han, Jieun Oh, Chun Soo Lim, In Mok Jung, Curie Ahn, Yon Su Kim, Jung Pyo Lee & Young Hoon Kim. (2017) Association of Serum Phosphorus Concentration with Mortality and Graft Failure among Kidney Transplant Recipients. Clinical Journal of the American Society of Nephrology 12:4, pages 653-662.
Crossref
Changlin Mei, Nan Chen, Xiaoqiang Ding, Xueqing Yu, Li Wang, Jiaqi Qian, Mei Wang, Gengru Jiang, Xuemei Li, Fanfan Hou, Li Zuo, Niansong Wang & Hong Liu. (2016) Efficacy and safety of Cinacalcet on secondary hyperparathyroidism in Chinese chronic kidney disease patients receiving hemodialysis. Hemodialysis International 20:4, pages 589-600.
Crossref
Kyla L. Naylor, Sophie A. Jamal, Guangyong Zou, Eric McArthur, Ngan N. Lam, William D. Leslie, Anthony B. Hodsman, S. Joseph Kim, Gregory A. Knoll, Lisa-Ann Fraser, Jonathan D. Adachi & Amit X. Garg. (2016) Fracture Incidence in Adult Kidney Transplant Recipients. Transplantation 100:1, pages 167-175.
Crossref
B. Rödiger, W. Zenk & J.-U. Wiegner. (2015) Multilokulärer Tumor im Bereich des GesichtsschädelsMultilocular tumor in the region of the viscerocranium. Der MKG-Chirurg 8:3, pages 170-172.
Crossref
Kyla L. Naylor & Amit X. Garg. (2014) Bone health in living kidney donors. Current Opinion in Urology 24:6, pages 624-628.
Crossref
Kyla L. Naylor, Eric McArthur, William D. Leslie, Lisa-Ann Fraser, Sophie A. Jamal, Suzanne M. Cadarette, Jennie G. Pouget, Charmaine E. Lok, Anthony B. Hodsman, Jonathan D. Adachi & Amit X. Garg. (2014) The three-year incidence of fracture in chronic kidney disease. Kidney International 86:4, pages 810-818.
Crossref
Jaime L Natoli, Rob Boer, Brian H Nathanson, Ross M Miller, Silvia Chiroli, William G Goodman & Vasily Belozeroff. (2013) Is there an association between elevated or low serum levels of phosphorus, parathyroid hormone, and calcium and mortality in patients with end stage renal disease? A meta-analysis. BMC Nephrology 14:1.
Crossref
Eid M El-Shafey, Ali E Alsahow, Khalid Alsaran, Alaa A Sabry & Mohamed Atia. (2011) Cinacalcet Hydrochloride Therapy for Secondary Hyperparathyroidism in Hemodialysis Patients. Therapeutic Apheresis and Dialysis 15:6, pages 547-555.
Crossref
Leonardo Lucchi, Chiara Carboni, Lucia Stipo, Vittoria Malaguti, Federica Ferrari, Romina Graziani, Silvia Arletti & Catia Graziosi. (2011) Early Initiation of Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients: A Three-Year Clinical Experience. Artificial Organs 35:12, pages 1186-1193.
Crossref
Kentaro Wada, Yuko Wada & Yasuhiko Iino. (2011) Two cases of acute renal hemorrhage undergoing maintenance hemodialysis after concurrent administration of cinacalcet. Clinical and Experimental Nephrology 15:5, pages 783-787.
Crossref
Greg L. Plosker. (2011) Cinacalcet. PharmacoEconomics 29:9, pages 807-821.
Crossref
Kamyar Kalantar-Zadeh, Jessica E Miller, Csaba P Kovesdy, Rajnish Mehrotra, Lilia R Lukowsky, Elani Streja, Joni Ricks, Jennie Jing, Allen R Nissenson, Sander Greenland & Keith C Norris. (2010) Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients. Journal of Bone and Mineral Research 25:12, pages 2724-2734.
Crossref
Linda M. McCann & Judith Beto. (2010) Roles of Calcium-Sensing Receptor and Vitamin D Receptor in the Pathophysiology of Secondary Hyperparathyroidism. Journal of Renal Nutrition 20:3, pages 141-150.
Crossref
Mark D. Danese, Vasily Belozeroff, Karen Smirnakis & Kenneth J. Rothman. (2008) Consistent Control of Mineral and Bone Disorder in Incident Hemodialysis Patients. Clinical Journal of the American Society of Nephrology 3:5, pages 1423-1429.
Crossref
Takashi Akiba, Tadao Akizawa, Yusuke Tsukamoto, Eiji Uchida, Manabu Iwasaki & Shozo Koshikawa. (2008) Dose Determination of Cinacalcet Hydrochloride in Japanese Hemodialysis Patients With Secondary Hyperparathyroidism. Therapeutic Apheresis and Dialysis 12:2, pages 117-125.
Crossref
J. B. Cannata-Andia & F. Carrera. (2008) The Pathophysiology of Secondary Hyperparathyroidism and the Consequences of Uncontrolled Mineral Metabolism in Chronic Kidney Disease: The Role of COSMOS. Clinical Kidney Journal 1:suppl 1, pages i2-i6.
Crossref
Katja Schlosser, Johannes A Veit, Stefan Witte, Emilio Domínguez Fernández, Norbert Victor, Hans-Peter Knaebel, Christoph M Seiler & Matthias Rothmund. (2007) Comparison of total parathyroidectomy without autotransplantation and without thymectomy versus total parathyroidectomy with autotransplantation and with thymectomy for secondary hyperparathyroidism: TOPAR PILOT-Trial. Trials 8:1.
Crossref
Rajeev Narayan, Robert M. Perkins, Elizabeth P. Berbano, Christina M. Yuan, Robert T. Neff, Eric S. Sawyers, Fred E. Yeo, Gwenaelle M. Vidal-Trecan & Kevin C. Abbott. (2007) Parathyroidectomy Versus Cinacalcet Hydrochloride–Based Medical Therapy in the Management of Hyperparathyroidism in ESRD: A Cost Utility Analysis. American Journal of Kidney Diseases 49:6, pages 801-813.
Crossref
N. Ozgen, M. Terashima, T. Aung, Y. Sato, C. Isoe, T. Kakuta & A. Saito. (2004) Evaluation of long-term transport ability of a bioartificial renal tubule device using LLC-PK1 cells. Nephrology Dialysis Transplantation 19:9, pages 2198-2207.
Crossref
. (2004) Cinacalcet for Secondary Hyperparathyroidism in Hemodialysis Recipients. New England Journal of Medicine 351:2, pages 188-189.
Crossref
Geoffrey A. Block, Kevin J. Martin, Angel L.M. de Francisco, Stewart A. Turner, Morrell M. Avram, Michael G. Suranyi, Gavril Hercz, John Cunningham, Ali K. Abu-Alfa, Piergiorgio Messa, Daniel W. Coyne, Francesco Locatelli, Raphael M. Cohen, Pieter Evenepoel, Sharon M. Moe, Albert Fournier, Johann Braun, Laura C. McCary, Valter J. Zani, Kurt A. Olson, Tilman B. Drüeke & William G. Goodman. (2004) Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis. New England Journal of Medicine 350:15, pages 1516-1525.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.